SBIR/STTR Research Award

Radiofrequency-multiplexed parallel flow cytometer for high content screening and drug discovery

Award identifier 8231c81d746e2344fb9a76346e04dbc6e23c78d71b35a694694c205515617c53Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$699,787

Program and phase

SBIR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Omega Biosystems Incorporated
Proposal award date
2015-01-15
Contract end date
2017-01-03
UEI
Not reported
Solicitation number
PA11-335
Topic code
300

Research abstract

DESCRIPTION provided by applicant Drug discovery is an extremely lengthy and expensive process On average drugs today cost more than $ billion to develop and take more than a decade to reach the market Most drugs today are discovered using high throughput screening in which hundreds of thousands to millions of trial compounds are assayed against cells to determine if they interact with a disease target This is typically performed using at the well level using techniques such as fluorescence chemiluminescence and optical absorbance to measure a cell populationandapos s average response to a drug While these techniques are high throughput they lack the ability to interrogate wells at the single cell level which provides a much more comprehensive picture of the phenotypic drug cell interaction than population averaged measurement do Flow cytometry is a well established and widely used technique used in most areas of cell biology that provides multi parameter cell level phenotypic information by measuring optical scatter and fluorescence information from individual cells in flow at a high throughput cells second While this cellular throughput is high the sample throughput of flow cytometers is low compared to fluorescence plate readers for example This speed limitation is primarily due to the serial sample handling approach employed by flow cytometers If this speed limitation could be eliminated flow cytometry could be used in primary screening assays The high content phenotypic information obtained by using flow cytometry early in the drug discovery process would enable researchers to more readily understand a candidate compoundandapos s complex intra and inter cellular effects This transformation in the compound screening process would increase the efficiency of drug discovery by elucidating complex drug cell interactions at an earlier stage ultimately reducing the overall cost and time to market of new drugs Here we propose to develop a parallel flow cytometer system using a novel optical technology known as Fluorescence Imaging using Radiofrequency tagged Emission or FIRE FIRE is a high speed optical technique that enables a single photomultiplier tube detector to measure fluorescence or optical scatter signals from multiple points on a sample using radiofrequency domain multiplexing We will use a modified FIRE optical system to probe fluorescence and scatter from cells flowing in parallel flow channels This instrument will simultaneously collect flow cytometry data from samples aspirated from well plates using a multi probe autosampler We will design construct and characterize the system using standard protocols and perform a relevant screening assay to test its performance This system will enable a well plate to be sampled in less than minutes ultimately enabling high content compound screening of more than wells per day using flow cytometry PUBLIC HEALTH RELEVANCE An instrument capable of analyzing cells flowing in parallel is proposed for improving the drug discovery process This instrument will enable candidate drug compounds to be screened at a rate approximately times faster than the current state of the art which will ultimately improve the efficiency at which researchers discover new pharmaceuticals

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.